Photo detail

Insys Therapeutics founder John Kapoor leaves federal court Jan. 30, 2019, in Boston. The Justice Department says opioid manufacturer Insys Therapeutics has agreed to pay $225 million to settle federal criminal and civil investigations. (Steven Senne/AP, File)

Donate Report a Typo Contact

Stories this photo appears in:

Tease photo

An opioid manufacturing company whose founder was convicted of racketeering conspiracy for bribing doctors to prescribe its highly addictive fentanyl spray has filed for bankruptcy protection.

By Associated Press June 11, 2019